NxThera, Inc., a medical device company pioneering the application of its Convective Water Vapor Energy (WAVE®) technology to treat endourological conditions, today announced publication of a recent economic analysis which demonstrates its minimally invasive Rezūm System to be a cost-effective and durable solution in treating benign prostatic hyperplasia (BPH).
